MetaCap

PMGC (ELAB) vs Alaunos Therapeutics (TCRT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.

Summary

PMGC is the larger company by market cap ($2.5 million vs $2.3 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ELAB-1.91%TCRT-6.24%
+0%-3%-7%
Oct 7, 20261 yearOct 9, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ELAB versus TCRT key metrics
MetricELABTCRT
Share price$3.08$0.7858
Market cap$2.49M$2.30M
1-day change-0.96%+0.61%
EPS (TTM)$-1,748.36$-1.76
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$2,671.20$4.50
52-week low$2.59$0.72
Distance from 52-week high-99.88%-82.54%
Average volume127.38K809.68K
Shares outstanding809.58K2.93M
Employees321
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About PMGC

ELAB stock →

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.

Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees

About Alaunos Therapeutics

TCRT stock →

Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs.

Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees

ELAB vs TCRT FAQ

Which is bigger, PMGC or Alaunos Therapeutics?

PMGC (ELAB) is larger, with a market capitalization of $2.49M compared with $2.30M for Alaunos Therapeutics (TCRT).

Are PMGC and Alaunos Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons